SWOG clinical trial number
S0340
A Prospective Observational Study of Patients with Solitary Plasmacytoma Using a Modified Staging System Supplemented by an MRI and Whole Body FDG-PET Scan
2% Accrual
Accrual
2%
Closed
Phase
2% Accrual
Accrual
2%
Research committees
Myeloma
Eligibility Criteria Expand/Collapse
Other Clinical Trials
S2213
SWOG Clinical Trial Number
Research Committee(s)
Myeloma
Activated
12/01/2023
4% Accrual
Accrual
4%
Open
Phase
S2209
SWOG Clinical Trial Number
Research Committee(s)
Myeloma
Activated
05/30/2023
17% Accrual
Accrual
17%
Open
Phase
S2005
SWOG Clinical Trial Number
Research Committee(s)
Myeloma
Activated
06/24/2021
17% Accrual
Accrual
17%
Open
Phase